RITUXIMAB AND METHYLPREDNISONE (RMP) IS A USEFUL AND EFFECTIVE ALTERNATIVE IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - PRELIMINARY RESULTS
ANNALS OF ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2011)